Showing results (71-80 of 179) with videos related to

Sort By:
Pageof 18
JAMA|February 18, 2015
Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarctionKarolina Szummer, Jonas Oldgren, Lars Lindhagen, et al.
Heart (British Cardiac Society)|November 11, 2015
Dabigatran etexilate and reduction in serum apolipoprotein BPhilip Joseph, Guillaume Pare, Lars Wallentin, et al.
Heart (British Cardiac Society)|May 6, 2014
Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudyZiad Hijazi, Jonas Oldgren, Ulrika Andersson, et al.
American Heart Journal|August 2, 2017
Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trialZiad Hijazi, Jonas Oldgren, Ulrika Andersson, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|June 5, 2025
Alcohol Intake and Cardiovascular Outcomes in Patients With Atrial Fibrillation: RE-LY AF Registry AnalysisAlireza Oraii, David Conen, Linda S Johnson, et al.
American Heart Journal|February 16, 2018
Design of DISCO-Direct or Subacute Coronary Angiography in Out-of-Hospital Cardiac Arrest studyRickard Lagedal, Ludvig Elfwén, Stefan James, et al.
Journal of the American College of Cardiology|July 18, 2018
Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial FibrillationAnthony P Kent, Martina Brueckmann, Mandy Fraessdorf, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 29, 2020
Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trialsGiuseppe Gargiulo, Christopher P Cannon, Charles Michael Gibson, et al.
Circulation|March 1, 2012
Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudyZiad Hijazi, Jonas Oldgren, Ulrika Andersson, et al.
European Heart Journal|September 28, 2020
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillationLars Wallentin, Johan Lindbäck, Niclas Eriksson, et al.
Pageof 18